Recent Finacing
Recent Raise
OmniSeq is a CAP-accredited molecular diagnostics lab that provides NGS-based genomic and immune profiling assays—including a 144-gene tumor panel and an Immune Report Card—to guide oncology treatment, trials.
Focus Areas
Recent Investors
Funding rounds
Investors
See the team members at OmniSeq.
